In our research, we found that in CRC cells the decreased expression of miR-106b-5p, the inhibition of the expression of angiogenesis factor VEGF, reversed EMT process through increasing the expressions of E-cadherin and decreasing N-cadherin and Vimentin via targeting FAT4. The gene discussed is CDH2; the disease is colorectal carcinoma.